We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
BancFirst
BANF
$3.8B
| $3.63M | ﹤0.01% |
60,381
+2,513
| +4% | +$144K |
|
1552
AtriCure
ATRC
$2.11B
| $3.62M | ﹤0.01% |
52,093
+1,856
| +4% | +$143K |
|
|
DEN
1553
DELISTED
Denbury Inc.
DEN
| $3.62M | ﹤0.01% |
51,558
+1,816
| +4% | +$125K |
|
1554
Standex International
SXI
$4.12B
| $3.61M | ﹤0.01% |
36,512
-4,754
| -12% | -$452K |
|
1555
G-III Apparel Group
GIII
$1.5B
| $3.61M | ﹤0.01% |
127,481
-15,596
| -11% | -$470K |
|
1556
Evolent Health
EVH
$447M
| $3.61M | ﹤0.01% |
116,349
+2,699
| +2% | +$64.8K |
|
1557
Cohu
COHU
$2.5B
| $3.6M | ﹤0.01% |
112,730
-17,982
| -14% | -$612K |
|
1558
Clearway Energy Class C
CWEN
$6.7B
| $3.57M | ﹤0.01% |
117,872
+4,744
| +4% | +$141K |
|
1559
US Physical Therapy
USPH
$1.22B
| $3.56M | ﹤0.01% |
32,224
-4,741
| -13% | -$540K |
|
1560
Red Rock Resorts
RRR
$3.62B
| $3.56M | ﹤0.01% |
69,523
+1,889
| +3% | +$82.5K |
|
|
BBBY
1561
Bed Bath & Beyond
BBBY
$442M
| $3.56M | ﹤0.01% |
50,207
-16
| -0% | -$1.11K |
|
1562
Allison Transmission
ALSN
$9.82B
| $3.55M | ﹤0.01% |
100,619
-24,187
| -19% | -$923K |
|
1563
Enova International
ENVA
$6.29B
| $3.55M | ﹤0.01% |
102,833
-13,842
| -12% | -$452K |
|
|
QVCGA
1564
DELISTED
QVC Group Inc Series A
QVCGA
| $3.55M | ﹤0.01% |
6,972
-558
| -7% | -$314K |
|
1565
United Parks & Resorts
PRKS
$2.12B
| $3.54M | ﹤0.01% |
63,969
+1,182
| +2% | +$59.5K |
|
1566
Corcept Therapeutics
CORT
$12B
| $3.54M | ﹤0.01% |
179,625
-39,987
| -18% | -$837K |
|
1567
James River Group Holdings
JRVR
$217M
| $3.53M | ﹤0.01% |
93,658
-13,722
| -13% | -$501K |
|
1568
Regenxbio
RGNX
$708M
| $3.53M | ﹤0.01% |
84,147
-8,634
| -9% | -$311K |
|
1569
Southside Bancshares
SBSI
$967M
| $3.52M | ﹤0.01% |
92,010
-9,601
| -9% | -$353K |
|
|
ECHO
1570
DELISTED
Echo Global Logistics, Inc.
ECHO
| $3.52M | ﹤0.01% |
73,789
-10,006
| -12% | -$346K |
|
1571
CareDx
CDNA
$2.42B
| $3.5M | ﹤0.01% |
55,271
+1,731
| +3% | +$132K |
|
|
NEWR
1572
DELISTED
New Relic, Inc.
NEWR
| $3.5M | ﹤0.01% |
48,792
-1,818
| -4% | -$134K |
|
1573
Astec Industries
ASTE
$1.02B
| $3.5M | ﹤0.01% |
64,989
-8,299
| -11% | -$490K |
|
1574
MACOM Technology Solutions
MTSI
$23.7B
| $3.49M | ﹤0.01% |
53,868
+1,745
| +3% | +$107K |
|
1575
Warrior Met Coal
HCC
$4.86B
| $3.47M | ﹤0.01% |
149,038
-18,528
| -11% | -$375K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.